Tekla Capital Management LLC Accelerate Diagnostics, Inc Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 14, 2018
SELL
$18.0 - $30.0 $2.7 Million - $4.5 Million
-150,000 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$21.1 - $25.15 $1.06 Million - $1.26 Million
50,000 Added 50.0%
150,000 $3.37 Million
Q2 2017

Aug 14, 2017
BUY
N/A
100,000
100,000 $2.74 Million

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email